Join the Oncology Voice Network. Join for Free
The 3 “Knows” of Effective Scientific Communication
scientific communication Medical Science Liaisons audience analysis storytelling techniques Key Opinion Leaders

The 3 “Knows” of Effective Scientific Communication


Share This Article


Summary

In this episode, Tom Caravela is joined by guest Linda Traylor who discusses the 3 "knows" of scientific communication for Medical Science Liaisons (MSLs). She shares the framework of scientific communication and its impact on the value and expectations of medical affairs. Self-awareness and audience analysis are emphasized to enhance engagement. The episode highlights common mistakes in audience interaction and data contextualization, offering professional development tips. It also covers storytelling techniques and strategies for effective meetings with Key Opinion Leaders (KOLs). The episode concludes with a book recommendation, acknowledgment of guest expertise, and additional resources.

Key Points

  • Understanding and adapting to the evolving landscape of scientific communication, including the use of AI tools and digital platforms, is crucial for medical affairs teams.
  • MSLs should focus on the three essential aspects of effective communication: knowing themselves, knowing their audience, and knowing their subject, to maximize engagements with healthcare professionals.
  • Building self-awareness through tools like personality assessments, aligning communication styles with the audience to eliminate distractions, and contextualizing data within the patient, HCP, and product journeys are key strategies for successful scientific exchanges.

Click for Source
scientific communication, Medical Science Liaisons, audience analysis, storytelling techniques, Key Opinion Leaders

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN